key: cord-0960384-lmxv04ze
authors: Matheny, Meghan; Maleque, Noble; Channell, Natalie; Eisch, A. Robin; Auld, Sara C.; Banerji, Aleena; Druey, Kirk M.
title: Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series
date: 2021-06-15
journal: Ann Intern Med
DOI: 10.7326/l21-0250
sha: 3ca1ad98d4ac56bfac370f8fc3afe39818f8d75c
doc_id: 960384
cord_uid: lmxv04ze

nan

Results of blood cultures and nasal swab polymerase chain reaction tests for SARS-CoV-2 were negative. After she developed additional SCLS-related complications and continued to deteriorate, care was discontinued on hospital day 7. Patient 2 had a normal vaginal delivery in 2002 followed by hypotension and edema, which was attributed to amniotic fluid embolism. In 2018, she had another episode of hypotension (systolic blood pressure was approximately 50 mm Hg) and anasarca after several days of upper respiratory symptoms. This episode was attributed to sepsis, although blood culture results were negative. In February 2021, she presented to the emergency department of Virginia Hospital Center 2 days after receiving the second dose of the mRNA-1273 vaccine (Moderna). She had hypotension and tachycardia and later developed shock and anasarca. Results from a nasal swab polymerase chain reaction test for SARS-CoV-2 and a screen for other common respiratory pathogens ( Table 1) were negative. All symptoms resolved with supportive treatment. Treatment with IVIG was started; monoclonal gammopathy of unknown significance (IgG κ) was detected during an asymptomatic period. Patient 3 had syncope and seizures in December 2020 and again in February 2021. His neurologic work-up, which included an electroencephalogram and magnetic resonance imaging of the brain, was normal. In April 2021, he presented to the local emergency department 1 day after receiving the second dose of the BNT162b2 vaccine (Pfizer-BioNTech). He had tachycardia and developed status epilepticus and was transferred to Maine Medical Center. During transport, he developed a cardiac arrest with pulseless electrical activity, which responded to cardiopulmonary resuscitation and epinephrine. Blood and urine cultures were negative, as were results from multiple nasal swab polymerase chain reaction tests for SARS-CoV-2. Monoclonal gammopathy of unknown significance was not detected by serum or urine immunofixation during the hospitalization. 

We describe 3 patients with SCLS or a history suggestive of SCLS who developed life-threatening flares 1 to 2 days after COVID-19 vaccination. We believe these patients identify SCLS as a risk factor for the development of serious adverse reactions after COVID-19 vaccination. However, we recognize that these observations do not rule out other causes of these flares. For example, infection-related symptoms precede 44% to 64% of all acute flares (1,4), and flares have been reported with SARS-CoV-2 infection (5). However, we were unable to identify any of these other triggers.

Systemic capillary leak syndrome is a rare disease, and persons without a diagnosis of SCLS or a history suggestive of SCLS are unlikely to develop a flare after COVID-19 vaccination. However, some persons with unexplained episodes of hypotension and edema may have undiagnosed SCLS. In addition, we note that none of the 3 patients we describe were receiving IVIG prophylaxis when they were vaccinated and that we have received no reports of SCLS flares after COVID-19 (or other antiviral) vaccinations among our 78 patients with SCLS, most of whom are receiving IVIG prophylaxis. Therefore, we recommend that patients with a diagnosis or a suspected diagnosis of SCLS should receive IVIG prophylaxis before vaccination. 

Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome: a systematic review

EurêClark Study Group. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission

EurêClark Study Group. Intravenous immunoglobulins improve survival in monoclonal gammopathyassociated systemic capillary-leak syndrome

Idiopathic systemic capillary leak syndrome (Clarkson disease)

SARS-CoV-2 induces acute and refractory relapse of systemic capillary leak syndrome (Clarkson's disease)